Clinical Trial Update: The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed the hemodynamic effects of SGLT2 inhibitors in acute decompensated heart failure and the study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: University of Chicago | Conditions: Acute Decompensated Heart Failure | Phase 4 | Status: TERMINATED | Results posted: 2023-12-06